EBITDA margin declined by 50bps YoY to 11.1% on account of suboptimal revenue growth & weak operating performance. Q1 volume de-grew by 19% YoY, but we expect revival in revenue growth from H2FY21E, led by revival in rural & agri demand and gradual pick-up in business as Covid-19 related issues moderate. Though we are positive on long term growth outlook of SIL, the current premium valuation is not sustainable. We value SIL at P/E of...